Sulfamethoxazole Trimethoprim Tablets are potentiated sulfonamide broad spectrum antimicrobial agents used to treat susceptible bacterial infections.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria including:

Urinary Tract Infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis and Proteus vulgaris. It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single e  ective antibacterial agent rather than the combination.

Acute Otitis Media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim tablets offers some advantage over the use of other antimicrobial agents.Sulfamethoxazole and trimethoprim tablets are not indicated for prophylactic or prolonged administration in otitis media at any age.

Acute Exacerbations of Chronic Bronchitis in Adults due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when a physician deems that sulfamethoxazole and trimethoprim tablets could offer some advantage over the use of a single antimicrobial agent.

Shigellosis: For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated.

Pneumocystis jirovecii Pneumonia and for prophylaxis against P. jirovecii pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing P. jirovecii pneumonia.

Traveler’s Diarrhea in Adults due to susceptible strains of enterotoxigenic E. coli.

FDA approved under ANDA 090624, this product has been shown to be bioequivalent to the

reference product, Bactrim and Bactrim DS.

Available in:

• 400 mg/80 mg tablets in 100 count bottles.

• 800 mg/160 mg double strength tablets in 500 count bottles.

For more information about Cronus Pharma products please contact your authorized distributor.

1 (844) 227-6687

Cronus Pharma LLC is a fully integrated R&D, manufacturing, and marketing animal health pharmaceutical company located in East Brunswick, New Jersey. Dedicated to providing quality and cost-effective pharmaceuticals to the U.S. animal health market, our products are accessible to all veterinarians and pet owners through national and regional distributors.

Cronus Pharma © 2022 All Rights Reserved.

Please see the additional pages for product information, including caution statements.

Cronus Pharma © 2023 All Rights Reserved